AMAM 13D/13G Filings - Ambrx Biopharma Inc.

Real time Form 13D and 13G transaction reports:

Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
Shares have beem adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Goto Prev, 0, 1

Reported DateTime	Transaction Date	Type	Company Symbol	Filed By Symbol	Shares Owned % Owned	Shares Vs. Prev Report	View
2022-02-14 3:09 pm Sale	2021-12-31	13G	Ambrx Biopharma Inc. AMAM	Cormorant Asset Management LP	17,266,144 7.060%	-138,558 (-0.80%)	Filing History
2022-02-11 4:03 pm Sale	2021-12-31	13G	Ambrx Biopharma Inc. AMAM	HBM BIOVENTURES CAYMAN LTD	16,856,567 6.900%	-898,156 (-5.06%)	Filing History
2022-02-09 09:09 am Purchase	2022-02-08	13G	Ambrx Biopharma Inc. AMAM	FMR CORP	26,985,175 9.996%	26,985,175 (New Position)	Filing History
2022-02-08 4:01 pm Purchase	2021-12-31	13G	Ambrx Biopharma Inc. AMAM	WuXi PharmaTech Healthcare Fund I L.P.	29,267,687 12.000%	29,267,687 (New Position)	Filing History
2022-01-18 4:30 pm Purchase	2022-01-05	13G	Ambrx Biopharma Inc. AMAM	ADAGE CAPITAL PARTNERS GP LLC	14,191,037 5.800%	14,191,037 (New Position)	Filing History
2021-07-12 4:56 pm Purchase	2021-06-22	13G	Ambrx Biopharma Inc. AMAM	Artal Participations S.a r.l	15,066,043 5.700%	15,066,043 (New Position)	Filing History
2021-07-02 4:12 pm Purchase	2021-06-22	13G	Ambrx Biopharma Inc. AMAM	Cormorant Asset Management LP	17,404,702 6.600%	17,404,702 (New Position)	Filing History
2021-07-02 4:00 pm Purchase	2021-06-22	13G	Ambrx Biopharma Inc. AMAM	HBM BIOVENTURES CAYMAN LTD	17,754,723 6.700%	17,754,723 (New Position)	Filing History

Goto Prev, 0, 1